Chagas disease is caused by Trypanosoma cruzi, being considered a public health problem. An alternative to combat this pathogen is the use of natural products isolated from fruits such as Eugenia uniflora, a plant used by traditional communities as food and medicine due to its antimicrobial and biological activities. Ethanolic extract from E. uniflora was used to evaluate in vitro anti-epimastigote and cytotoxic activity. This is the first record of anti-Trypanosoma activity of E. uniflora, demonstrating that a concentration presenting 50% of activity (EC(50)) was 62.76 μg/mL. Minimum inhibitory concentration (MIC) was ≤ 1024 μg/mL. Our results indicate that E. uniflora could be a source of plant-derived natural products with anti-epimastigote activity with low toxicity.
Candidiasis is the most frequent infection by opportunistic fungi such as Candida albicans, Candida tropicalis, and Candida krusei. Ethanol extract from Eugenia uniflora was assayed, for its antifungal activity, either alone or combined with four selected chemotherapeutic antimicrobial agents, including anphotericin B, mebendazole, nistatin, and metronidazole against these strains. The obtained results indicated that the association of the extract of E. uniflora to metronidazole showed a potential antifungal activity against C. tropicalis. However, no synergistic activity against the other strains was observed, as observed when the extract was associated with the other, not enhancing their antifungal activity.
Our results indicate that M. charantia could be a source of plant-derived natural products with antiepimastigote and antifungal-modifying activity with moderate toxicity.
Background: Although broad-band ultraviolet (UV)-A has been described as a therapeutic option for various skin diseases, there are few studies investigating the efficacy of UV-A irradiation in treating diseases related to infectious agents. Objective: Evaluate the light-enhanced antibacterial activity of Brazilian medical plants, Croton campestris A (Euphorbiaceae), Ocimum gratissimum L. (Lamiaceae), and Cordia verbenaceae DC (Boraginaceae). Methods: Hexane extracts of Croton campestris A., Ocimum gratissimum L., and Cordia verbenaceae DC were assayed using a UV-A exposure method against strains of Staphylococcus aureus and Escherichia coli. Assays were performed in triplicate with and without exposure to UV-A radiation to test for light-activated or lightenhanced antibacterial activity. Results: All extracts showed activity against the S. aureus strain. Extracts of O. gratissimum and C. verbenaceae were the most active after exposure to UV-A light, with an increase in antibacterial activity of 140 and 100%, respectively. No extract showed light-activated antibacterial activity against E. coli. Conclusion: C. campestris, O. gravissimum and C. verbenaceae showed light-enhanced antibiotic activity. This suggests that phytochemical investigations may be warranted.
Background:This study evaluates the radical-scavenging activity of five plants used as food and medicines in the northeastern region of Brazil.Materials and Methods:Spectrophotometric analysis of the plants’ ethanol extracts was carried out. The antioxidant activity was determined by the DPPH (2,2-diphenyl-1 picrylhydrazyl) test. The antioxidant capacity was measured using ascorbic acid as a positive control.Results:All tested plant extracts showed an antioxidant activity, but the highest activity was observed with the extracts of Momordica charantia and Eugenia jambolana.Conclusions:Therefore, these species must be studied as a putative source of products for use in the prevention and treatment of diseases in which oxidants or free radicals are implicated.
Background:Escherichia coli is known to produce enterotoxins whose properties and role in diarrheal disease have been extensively investigated; besides, this bacterium is related to several extra-intestinal problems in the intensive care unit and in surgical wound infections. Some species of Staphylococcus are recognized as etiological agents of opportunistic infections in animals and humans. This study is the first test on the modulation of antibiotic activity by Croton campestris A. against multiresistant strains of E. coli and Staphylococcus aureus. Methods: In this study, the hexane and methanol extract of C. campestris A. was tested for antibacterial activity alone and in combination with aminoglycosides against bacterial strains. The synergy of the methanol and hexane extract was verified by microdilution method. Results: A synergistic effect of both extracts combined with the aminoglycosides was demonstrated. Conclusions: It is suggested that the extracts from C. campestris A. could be used as a source of natural product derived from this plant with resistance-modifying antibacterial activity, providing a new weapon against the problem of bacterial resistance to antibiotics.
The search for new therapeutic agents has been a constant for the treatment of diseases such as leishmaniasis and Chagas disease. Most drugs used have side effects, justifying the need to evaluate the cytotoxicity of the tested products for candidates to new drugs. In this study, the bioactivity of Lygodium venustum, a cosmopolitan fern of Lygodiaceae, was assessed about their leishmanicidal and trypanocidal potential. The better activity was observed using methanol fraction, with inhibition percentage of 63% and 68% for promastigotes and epimastigotes, respectively, at a concentration of 500 μg/mL. The ethyl acetate and methanol fractions demonstrated a higher cytotoxic potential. This was the first report of leishmanicidal, trypanocidal and cytotoxic activities to L. venustum.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.